The impact of extended-Cycle vaginal ring contraception on migraine aura: A retrospective case series

Headache

Volumn 52, Issue 8, 2012, Pages 1246-1253

  Calhoun, Anne ^a   Ford, Sutapa ^a   Pruitt, Amy ^b  

^a Carolina Headache Institute   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

contraceptive; estrogen; menstrual migraine; migraine with aura; stroke risk

Indexed keywords

ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; GESTAGEN;

ABDOMINAL PAIN; ADULT; ARTICLE; CHEIROORAL NUMBNESS; CLINICAL ARTICLE; DRUG WITHDRAWAL; ESTROGEN THERAPY; FACIAL SWELLING; FEMALE; HUMAN; LOW DRUG DOSE; MENSTRUAL MIGRAINE; MENSTRUATION; MIGRAINE; MIGRAINE AURA; NAUSEA; PARESTHESIA; PHOTOPSIA; PILOT STUDY; POSTOVULATORY MIGRAINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCOTOMA; STROKE; SWELLING; TREATMENT RESPONSE; VAGINA RING; VISUAL DISORDER; WITHDRAWAL SYNDROME;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; DATABASES, FACTUAL; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE WITH AURA; PILOT PROJECTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84865865868     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02211.x     Document Type: Article

References (19)

1. Donaghy M, Chang CL, Poulter N,. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002; 73: 747-750.
2. Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women. Associated risk factors. JAMA. 1975; 231: 718-722.
3. MacGregor EA,. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004; 3: 354-361.
4. Bigrigg A, Evans M, Gbolade B, et al,. Depo Provera. Position paper on clinical use, effectiveness and side effects. Br J Fam Plann. 1999; 25: 69-76.
5. Sulak P, Willis S, Kuehl T, Coffee A, Clark J,. Headaches and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache. 2007; 47: 27-37.
6. De Leo V, Scolaro V, Musacchio MC, Di Sabatino A, Morgante G, Cianci A,. Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril. 2011; 96: 917-920.
7. Calhoun A, Ford S,. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache. 2008; 48: 1186-1193.
8. Kurth T, Slomke MA, Kase CS, et al,. Migraine, headache, and the risk of stroke in women: A prospective study. Neurology. 2005; 64: 1020-1026.
9. Kurth T,. The association of migraine with ischemic stroke. Curr Neurol Neurosci Rep. 2010; 10: 133-139.
10. Calhoun A,. Combined hormonal contraceptives: Is it time to reassess their role in migraine? Headache. 2012; 52: 648-660.
11. Killick S,. Complete and robust ovulation inhibition with NuvaRing. Eur J Contracept Reprod Health Care. 2002; 7 (Suppl. 2): 13-18. discussion 37-19.
12. Calhoun AH,. A novel specific prophylaxis for menstrual-associated migraine. South Med J. 2004; 97: 819-822.
13. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia. 2004; 24: 1-160.
14. Kosinski M, Bayliss MS, Bjorner JB, et al,. A six-item short-form survey for measuring headache impact: The HIT-6. Qual Life Res. 2003; 12: 963-974.
15. Nappi RE, Sances G, Allais G, et al,. Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: A prospective diary-based pilot study. Contraception. 2011; 83: 223-228.
16. Somerville BW,. The role of progesterone in menstrual migraine. Neurology. 1971; 21: 853-859.
17. ACOG Committee on Practice Bulletins. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006; 107: 1453-1472.
18. Birtch RL, Olatunbosun OA, Pierson RA,. Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use. Contraception. 2006; 73: 235-243.
19. Baerwald AR, Pierson RA,. Ovarian follicular development during the use of oral contraception: A review. J Obstet Gynaecol Can. 2004; 26: 19-24.